Avery Dennison Reports Mixed Q1 Earnings

Avery Dennison Corp (NYSE: AVY) reported a first-quarter FY23 sales decline Wednesday of 12.1% year-on-year to $2.06 billion, missing the analyst consensus estimate of $2.18 billion.

Avery Dennison Corp (NYSE:AVY) reported a first-quarter FY23 sales decline Wednesday of 12.1% year-on-year to $2.06 billion, missing the analyst consensus estimate of $2.18 billion.

Reported sales for the Materials group decreased by 13% to $1.5 billion and Solutions Group declined 11% to $605 million.

Gross profit fell 15.4% Y/Y to $542.3 million.

Marketing, general and administrative expenses declined 5.8% Y/Y to $334.4 million.

It reported an operating margin of 9.2%, with operating income declining 34% to $190.1 million.

The company held $351.3 million in cash and equivalents as of April 1, 2023. Net cash provided by operating activities for the quarter was $1.9 million.

Adjusted EPS of $1.70 beat the consensus estimate of $1.66.

Outlook: Avery Dennison cut its FY23 adjusted EPS outlook to $8.85 – $9.20 (previously $9.15 – $9.55) versus the consensus of $9.28.

Price Action: AVY shares closed lower by 4.63% at $170.83 on Tuesday.

Total
0
Shares
Related Posts
Read More

Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ABEO